Annual Drug Patent Expirations for PROMACTA+KIT
Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
The generic ingredient in PROMACTA KIT is eltrombopag olamine. One supplier is listed for this compound. Additional details are available on the eltrombopag olamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
